49 results
8-K
EX-99.1
PSTX
Poseida Therapeutics Inc
7 Mar 24
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
4:05pm
compensation expense in the first quarter of 2023 related to a one-time expense associated with the retirement of the Company's former Executive Chairman
S-8
EX-99.4
PSTX
Poseida Therapeutics Inc
8 Feb 24
Registration of securities for employees
4:10pm
is not assumed, continued or substituted, (iii) a Change in Control, or (iv) such Participant’s retirement (as such term may be defined in the Award
8-K
EX-99.1
nzy9zqr8zazwf 0z62pj
9 Nov 23
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023
4:05pm
8-K
EX-99.1
oj5iw7cr
8 Aug 23
Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023
4:06pm
8-K
EX-99.1
lstq6ond65hcl 5pu
9 May 23
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023
4:06pm
8-K
EX-1.1
13rdck
4 Aug 22
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
4:57pm
8-K
hx93csge9xp8iso3cf9i
10 Mar 22
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021
4:18pm
S-8
EX-99.4
kdf28m7
18 Feb 22
Registration of securities for employees
4:59pm
S-3
EX-4.7
viugy49e5vzapvjrax
13 Aug 21
Shelf registration
4:13pm